Haijima Norimasa, Kudo Mikihiko, Nakajima Shinntaro
Department of Cardiovascular Surgery, National Hospital Organization Saitama Hospital, Wako, Japan.
Kyobu Geka. 2022 May;75(5):353-356.
The third-generation Trifecta valve, Trifecta GT, has been used in Japan since 2012. The Trifecta GT is characterized by the external leaflet mounting, which increases the effective valve opening area and provide excellent hemodynamics. Lehmann et al. reported a good 8-year avoidance rate of 93.3% for structural valve deterioration( SVD) in 1,241 patients. There are three main causes of SVD after valve replacement using bioprostheses:pannus formation in the left ventricular outflow tract, calcification of the valve leaflets, and noncalcified leaflet tears. Goldman et al. reported 11 SVDs in 710 patients who underwent surgical implantation of Trifecta valve, 10 of which were due to calcification of the valve leaflets and only one of which was due to noncalcified leaflet tears. Herein, we report four cases of early SVD due to noncalcified leaflet tears after valve implantation using the Trifecta GT.
第三代Trifecta瓣膜(Trifecta GT)自2012年起在日本使用。Trifecta GT的特点是外部瓣叶安装,这增加了有效瓣口面积并提供了出色的血流动力学。Lehmann等人报告了1241例患者中结构性瓣膜退变(SVD)的8年良好避免率为93.3%。使用生物瓣膜进行瓣膜置换术后发生SVD的三个主要原因是:左心室流出道形成血管翳、瓣叶钙化以及非钙化瓣叶撕裂。Goldman等人报告了710例接受Trifecta瓣膜手术植入的患者中有11例发生SVD,其中10例是由于瓣叶钙化,只有1例是由于非钙化瓣叶撕裂。在此,我们报告了4例使用Trifecta GT进行瓣膜植入后因非钙化瓣叶撕裂导致的早期SVD病例。